Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen moving up

Executive Summary

Amgen will likely to be among the top 10 largest pharmaceutical manufacturers in U.S. sales by the end of 2003, IMS VP-Industry Relations Doug Long tells National Association of Chain Drug Stores conference Aug. 26 in Philadelphia. Noting that Amgen grew 34.4% to $6.67 bil. in sales for the 12 months through June, Long said "my prediction would be that when the year 2003 is over, Amgen will be in the top 10 pharmaceutical companies, making the first time a biotech company is in the top 10." Aventis currently holds the number 10 spot, with $6.73 bil. in sales for the 12 months through June (up 17.1%). The number nine and eight spots, held respectively by Lilly (up 4.6% to $7.15 bil.) and Wyeth (up 2.5% to $7.38 bil.), also appear to be within Amgen's reach...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS042380

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel